How to manage constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Constipation

For adults with chronic idiopathic constipation, start with polyethylene glycol (PEG) 17g in 8 oz water once or twice daily as first-line pharmacologic therapy, which has moderate-quality evidence showing durable response over 6 months. 1

Initial Assessment

Before initiating treatment, perform a focused evaluation:

  • Rule out bowel obstruction and fecal impaction through digital rectal examination (DRE) and abdominal examination 1, 2
  • Obtain medication history to identify constipating agents that can be discontinued (opioids, anticholinergics, calcium channel blockers) 1
  • Check for alarm symptoms: rectal bleeding, unintentional weight loss, sudden change in bowel habits 1
  • Consider plain abdominal X-ray if severe fecal loading or obstruction is suspected clinically 1
  • Check corrected calcium and thyroid function if clinically indicated 1

Stepwise Treatment Algorithm

Step 1: Lifestyle Modifications (Mild Constipation)

For patients with mild symptoms or dietary fiber deficiency:

  • Increase fluid intake to at least 2 liters daily, particularly for those in the lowest quartile of fluid consumption 1
  • Trial of fiber supplementation: Psyllium is the best-studied fiber, taken with 8-10 ounces of fluid per dose, up to 3 times daily 1, 3
  • Increase physical activity and establish regular toileting habits after meals 1
  • Ensure privacy and proper positioning (small footstool to assist with defecation) 1

Important caveat: Fiber supplementation has low-quality evidence and may cause flatulence and bloating. Studies are 30-40 years old with small sample sizes. 1 Bulk-forming laxatives like psyllium are unlikely to control opioid-induced constipation and should not be relied upon in that context. 1

Step 2: First-Line Pharmacologic Therapy

Polyethylene Glycol (PEG) is the recommended first-line agent:

  • Dose: 17g (one capful) dissolved in 8 oz water once or twice daily 1, 2
  • Evidence: Three randomized controlled trials show efficacy, with durable response over 6 months 1
  • Side effects: Abdominal distension, loose stool, flatulence, nausea 1
  • Safety profile: Excellent, with minimal systemic absorption 2

Alternative first-line option - Stimulant laxatives:

  • Bisacodyl: 10-15 mg daily, can increase to 2-3 times daily if needed 2
  • Senna with docusate: 2 tablets every morning, maximum 8-12 tablets per day 1, 2
  • Goal: One non-forced bowel movement every 1-2 days 1

Step 3: Second-Line Agents (Persistent Constipation)

If PEG or stimulant laxatives fail after several days:

  • Magnesium hydroxide: 30-60 mL daily (avoid in renal impairment due to hypermagnesemia risk) 1, 2
  • Lactulose: 30-60 mL daily 1
  • Sorbitol: 30 mL every 2 hours × 3, then as needed 1
  • Magnesium citrate or additional PEG dosing 1

Before escalating therapy: Reassess for bowel obstruction and check for fecal impaction 1, 2

Step 4: Rectal Interventions

For refractory constipation or fecal impaction:

Suppositories:

  • Glycerin suppository as first-line rectal intervention 2
  • Bisacodyl suppository: 10 mg rectally once or twice daily 1, 2

Enemas (if oral treatment fails):

  • Small-volume enemas: Sodium phosphate or docusate sodium enemas 1
  • Large-volume enemas: Normal saline (1000 mL) or warm water enemas for impaction 1
  • Oil retention enemas: For softening hard stool (hold 30+ minutes) 1

Manual disimpaction:

  • Digital fragmentation and extraction following premedication with analgesic ± anxiolytic 1, 2
  • Followed by enema or suppository, then maintenance oral regimen 1

Contraindications to enemas: Neutropenia, thrombocytopenia, recent colorectal/gynecological surgery, recent pelvic radiation, severe colitis, undiagnosed abdominal pain 1, 2

Step 5: Prokinetic Agents

For severe refractory cases:

  • Metoclopramide: 10-20 mg PO 3-4 times daily 1

Special Consideration: Opioid-Induced Constipation

Prophylaxis is essential - constipation does not improve over time with opioids, unlike other opioid side effects 1

Prevention strategy:

  • Start prophylactic laxatives with the first opioid dose 2
  • Stimulant laxative + stool softener: Senna/docusate 2 tablets every morning 1
  • Escalate laxative dose when increasing opioid dose 1
  • Avoid relying on fiber supplements - they are ineffective for opioid-induced constipation 1

If standard laxatives fail:

  • Consider opioid rotation to less constipating alternatives (e.g., transdermal fentanyl vs. oral morphine) 1
  • Combination opioid/naloxone preparations reduce constipation risk 1
  • Peripherally acting μ-opioid receptor antagonists (PAMORAs): Methylnaltrexone 0.15 mg/kg subcutaneously every other day for laxative-refractory cases 1, 2
  • Naloxegol is another PAMORA option 1

Common Pitfalls to Avoid

  • Do not use bulk-forming laxatives in patients with limited mobility or fluid intake - risk of obstruction 2
  • Avoid long-term magnesium-based laxatives in renal impairment - risk of hypermagnesemia and toxicity 2, 4
  • Do not perform enemas in neutropenic patients (WBC <0.5 cells/μL) - risk of bacteremia 1
  • Stop laxatives and seek evaluation if: constipation lasts >7 days, rectal bleeding occurs, or no bowel movement despite treatment 3, 5
  • Always rule out obstruction before aggressive laxative therapy 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Postoperative Constipation Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of Constipation in Older Adults.

American family physician, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.